Prof. Gal Markel
MD, PhD, MBA
Deputy Director General, Rabin Medical Center at Clalit Health Services
Prof. Markel is a leading oncologist in Israel and is a world known expert in the area of skin cancers as well as applications of Immuno-Oncology therapies.
During the course of his training and work, Prof. Markel has gained deep knowledge and extensive experience in providing cancer treatment. He is unique in his ability to integrate clinical expertise with original innovative clinical and biotechnological research.
Prof. Markel has been initiating and leading multiple innovative research and development programs, all aiming towards better understanding the basics of cancer and ultimately finding novel treatment solutions.
Hence, Prof. Markel is fully updated with all the latest global innovations and developments in his field.
Consultation Meeting
Prof. Markel consults patients in the Ramat Aviv Medical Center (Clinics Building at Ramat Aviv Mall, Tel Aviv), phone:
At the Consultation Meeting, Prof. Markel conducts a complete clinical evaluation and analysis of all medical information and records provided by the patient, in order to generate an updated clear status report.
Each case is thoroughly and carefully examined by Prof. Markel, to provide the patient with a rationalized, personalized, treatment plan, and how to execute it. Support to the patient and primary caregivers is emphasized.
What to bring
All relevant medical documents, including Pathology Reports, Imaging Reports, Medical Summaries, imaging magnetic media etc.
When scheduling the appointment for a Consultation Meeting, it is highly recommended to submit the documents in advance via email.
The Meeting will include a comrehensive outline of the medical status, the possibilities of the treatments and support for the Patient and the family to exercise the treatment plan and comply optimally with the disease.
Prof. Markel consults, guides and accompanies the treatments and the follow up of the patients of all stages of disease, including diagnostic directives, surgery plan recommendations, and the Oncological & Radiation recommendations, as required.
Melanoma Consultation
One of the principal expertise of Prof. Markel is the treatment of Melanoma.
When melanoma is diagnosed at an early stage, the cure rates are high, emphasizing the importance of the involvement of highly professional and experienced melanoma expert in the treatment process and follow up.
Optimal treatment of advanced melanoma mandates deep knowledge and experience with the disease and the biological and the immunological novel treatments.
Prof. Markel’s track record and intensive activity at the Ella Lemelbaum Institute, which he led, enables him to provide highly professional consultations.
Non Melanoma Skin Cancers
Prof. Markel is a leading expert in Non-Melanoma Skin Cancers as well.
Squamous cell carcinoma
Basal cell carcinoma
Merkel cell carcinoma
When these cancers are diagnosed at an early stage, the cure rates are high, emphasizing the importance of the involvement of highly professional and experienced expert in the treatment process and follow up.
However, when the disease has more aggressive characteristics, detected at an advanced stage, or is recurrent, the chances for cure are lower. These cases typically require cutting edge medical therapeutic modalities.
Today, novel biological and immunotherapeutic treatments are available for the treatment of patients with advanced Non-Melanoma Skin Cancers, requiring the consideration of skin cancer oncologist.
Prof. Markel’s track record and intensive activity at the Ella Lemelbaum Institute, which he heads, enables him to provide highly professional consultations.
Immuno - Oncology
Another principal expertise of Prof. Markel, is the implementation of Immuno-Oncology (immunotherapy) technologies for the treatment of cancer patients in general. The scope of Immuno-Oncology consultation includes:
Treatment compatibility with Immuno-Oncology agents.
Management of unique immune-related side effects and toxicities.
Administration of Immuno-Oncology treatments in complex clinical conditions, such as organ transplantation, active autoimmunity diseases etc.
This expertise is not limited to skin cancers, as it is relevant to any cancer patient treated with Immuno-Oncology agents.
About
Prof. Gal Markel is a board certified medical oncologist and is the Deputy Director General, Rabin Medical Center at Clalit Health Services.
Prof. Markel is among the cancer immunotherapy pioneers in Israel, and has global reputation in the fields of Immuno-Oncology, melanoma and skin cancers treatment and research.
Prof. Markel is a Professor in the Faculty of Medicine in Tel Aviv University, and is regularly invited to speak in leading medical and scientific conferences around the globe in his field of expertise. He has been able successful in integration of the worlds of medicine, research and innovation.
Collaborations
Prof Markel collaborates with leading physicians from the areas of dermatology, plastic surgery, head-neck surgery and general surgery, in order to generate personally-tailored treatment plans for optimal results.
Education and Training
Prof. Markel is a graduate of the Hadassah Hebrew University Medical School in Jerusalem (MD, Medical Doctor), where he also, in parallel, completed his PhD with highest honors, researching the relationship between the immune system and cancer.
He completed his Residency in Oncology in the Sheba Medical Center at Tel HaShomer, focusing on immuno-oncology, melanoma and skin cancers in the Ella Lemelbaum Institute.
In addition, Prof. Markel has also a Master in Business Administration (MBA) degree in the space of Healthcare Innovation, from the IDC Herzliya.
Clinical Areas
Prof. Markel is an expert medical oncologist with broad knowledge, experience and understanding of Cancer, with special focus on the following areas:
Skin Cancers
Melanoma, Squamous cell carcinoma, Basal cell carcinoma, Merkel cell carcinoma etc.
Immuno-Oncology
Expert consultation about compatibility to immuno-oncology treatment, immuo-oncology treatment in with complex patients, management of unique side effects etc.
Research Areas
Prof. Markel is an internationally recognized basic and clinical investigator in the fields of Melanoma and Immuno-Oncology. He is the author of about 120 articles in these fields in leading high impact journals.
His principal view is that the most valuable breakthroughs will evolve out of interdisciplinary integration question & materials from the clinical world and the R&D world under ‘one roof’.
Among Prof. Markel’s prime achievements are the development of a novel Immuno-Oncolgy drug, which is currently being tested in clinical trials; the development of therapeutic microbiome transplantations in combination with standard immuno-oncology treatments in cancer patients with resistant disease; the identification of new side effects of Immuno-Oncology drugs and how to treat them, and more.
Societies and professional Organizations
Prof. Markel is a member of the Israeli Society of Cancer Research from its founding and has been a member of its Executive Board between 2015-2019.
Member of the Israeli Society of Clinical Oncology and RadioTherapy.
Member of the European and American Companies of Oncology and Cancer Research (ESMO, AACR, ASCO).
Member of the Society of Melanoma Research.
